| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/05/2008 | EP1292289B1 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers |
| 03/05/2008 | EP1144609B1 Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
| 03/05/2008 | EP1064360B1 Luciferases, gfp fluorescent proteins, their nucleic acids and the use thereof in diagnostics |
| 03/05/2008 | EP1007720B1 Dendritic cell hybrids |
| 03/05/2008 | EP0989993B1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 03/05/2008 | CN101137700A Microparticle and pharmaceutical composition |
| 03/05/2008 | CN101137669A Method for cleaning marine collagen and the treatment thereof to form porous sponges |
| 03/05/2008 | CN101137666A HIV Vif mutant |
| 03/05/2008 | CN101137665A Desoxo-nonadepsipeptides |
| 03/05/2008 | CN101137392A Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
| 03/05/2008 | CN101137391A Recombinant super-compound interferon and uses thereof |
| 03/05/2008 | CN101137390A Novel angiogensis inhibitor |
| 03/05/2008 | CN101137349A Controlled release compositions for interferon based on PEGT/PBT block copolymers |
| 03/05/2008 | CN101135679A Insulinogen C peptide biological activity measuring method |
| 03/05/2008 | CN101134953A Recombinant human pancreas kininogenase |
| 03/05/2008 | CN101134952A Human urine kininogenase and method for making same |
| 03/05/2008 | CN101134780A Polypeptide analogue for blocking NR2B signal path and preparation method and medical usage thereof |
| 03/05/2008 | CN101134779A Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
| 03/05/2008 | CN101134775A Novel streptococcus antigens |
| 03/05/2008 | CN101134774A Combined chemical modified endomorphin-1 and method for preparing same |
| 03/05/2008 | CN101134773A Method for extracting corn free radical scavenger |
| 03/05/2008 | CN101134107A Antithrombotic agents |
| 03/05/2008 | CN101134106A Pharmaceutical composition containing human urine kininogenase for treating cerebral infarction |
| 03/05/2008 | CN101134105A Pharmaceutical composition containing recombination human pancreatic kininogenase for treating and/or preventing cerebral infarction |
| 03/05/2008 | CN101134104A Particle medicinal granules for treating pharyngitis and method of producing the same |
| 03/05/2008 | CN101134103A Food for enlarging breast |
| 03/05/2008 | CN101134102A 5T4 tumour-expressed antigen |
| 03/05/2008 | CN101134101A 5T4 tumour-associated antigen |
| 03/05/2008 | CN101134100A Use of steroid hormone synthesized acute regulation protein in the preparation of medicament for preventing and controlling fatty liver |
| 03/05/2008 | CN101134020A Method for producing recombination human body keratinized cell growth factor -2 freeze-dried powder for injection |
| 03/05/2008 | CN101133828A Antiaging polypeptide food product and method for preparing the same |
| 03/05/2008 | CN100373375C System and method for controlling user interface attribute by data |
| 03/05/2008 | CN100372944C The use of PDE4D in the screening for medicaments against atherosclerosis |
| 03/05/2008 | CN100372870C Polyethylene glycol derivatives of thymosin alphal |
| 03/05/2008 | CN100372869C Antimicrobial polypeptide from Amolops loloensis and its pharmaceutical use |
| 03/05/2008 | CN100372840C Intermediate for the preparation of epimino |
| 03/05/2008 | CN100372572C Recombinant plasmid with human thymosin Beta-4gene |
| 03/05/2008 | CN100372568C Application of compound MG 132 in preparation of medicine for treating leucocythemia |
| 03/05/2008 | CN100372567C Thrombin derived peptides for promoting cardiac tissue repair |
| 03/05/2008 | CN100372566C Targeted delivery of drugs for treatment of viral infections |
| 03/05/2008 | CN100372537C Use of tyrosine kinase inhibitor to treat diabetes |
| 03/04/2008 | US7339047 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases |
| 03/04/2008 | US7339046 CFTR with a partially deleted R domain and uses thereof |
| 03/04/2008 | US7339045 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, lipids, cells, virus particles, fatty acids, polysaccharides) |
| 03/04/2008 | US7339044 Nematode PAN and ZP receptor-like sequences |
| 03/04/2008 | US7339043 Compositions and methods for affecting virulence determinants in bacteria |
| 03/04/2008 | US7339039 Nucleic acids encoding receptor recognition factors, and methods of use thereof |
| 03/04/2008 | US7339038 Heparanase specific molecular probes and their use in research and medical applications |
| 03/04/2008 | US7339037 nucleoside sequence polypeptides; therapy, prevention of influenza viral infections |
| 03/04/2008 | US7339032 Polypeptides, fragments and homologues; vectors, host cells, antibodies; genetic engineering and expression; treatment of urogenital, sexual, metabolic, inflammatory, pregnancy, and g-protein coupled receptor disorders; drug screening |
| 03/04/2008 | US7339031 Cancer therapeutics; inhibits protein synthesis on ribosomes |
| 03/04/2008 | US7339030 Human semaphorin L (H-SemaL) and corresponding semaphorins in other species |
| 03/04/2008 | US7339029 Sperm-specific cation channel, CatSper2, and uses therefor |
| 03/04/2008 | US7339028 Mahoganoid polypeptides, and related compositions and methods |
| 03/04/2008 | US7339027 Human prolactin antagonist-angiogenesis inhibitor fusion proteins |
| 03/04/2008 | US7339026 mda-9 protein |
| 03/04/2008 | US7339025 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 03/04/2008 | US7339023 Angiogenesis inhibitors, antitumor agents |
| 03/04/2008 | US7339022 Histological certification of lymphatic vessels and the immunohistochemical inspection for malignant invasion into the lymphatic vessels; an epitope of a lymphatic vessel-specific antibody; immunostaining |
| 03/04/2008 | US7338939 Administering composition comprising hydrocodone covalently bound to a peptide; decreasing the bioavailability by intravenous or intranasal administration |
| 03/04/2008 | US7338938 Methods for treating a patient undergoing chemotherapy |
| 03/04/2008 | US7338937 Calcium-activated chloride channel proteins and their use in anti-metastatic therapy |
| 03/04/2008 | US7338936 Administering a defensin (EP2E) to treat infections caused by Hemophilus influenzae strain 12, Moraxella catarrhalis, or Streptococcus pneumoniae serotype 3 or serotype; labyrinthitis and meningitis |
| 03/04/2008 | US7338935 Isolating interferon polypeptides using size exclusion chromatography; antitumor agents; viricides; immunomodulators |
| 03/04/2008 | US7338934 Fibroblast growth factor-14 |
| 03/04/2008 | US7338933 Human Growth Hormone polypeptide comprising an O-linked glycosylation site that does not exist in a wild type polypeptide; glycoconjugates in which a species such as a water-soluble polymer, a therapeutic agent or a biomolecule is covalently linked through the site |
| 03/04/2008 | US7338932 Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments |
| 03/04/2008 | US7338931 Administering a hyaluronic acid and an insulin for treating diabetes; structure compacted due to the passing of the structure over its point of collapse with buried polar groups and a minimum size; the hyaluronic acid surrounds the insulin |
| 03/04/2008 | US7338930 Interleukin-17 receptors; tumor necrosis factor receptors; nitric oxide level regulators; may be used in conjunction with inhibitor of IL-1 and/or TNF. |
| 03/04/2008 | US7338807 Using expression vector coding tumor supressor protein to identify compounds which induce cell death; diagnosing xeroderma pigmentosum |
| 03/04/2008 | US7338794 Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant and vaccine accelerant |
| 03/04/2008 | US7338788 Cytokines; gene therapy; for treatment of multiple sclerosis and hepatitis |
| 03/04/2008 | US7338787 Lowering circulating free fatty acid levels in an individual by administering purified, isolated, or recombinant OBG3 or gOBG3 polypeptide fragment that has significantly greater activity than a full-length OBG3 polypeptide; treatment of hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/04/2008 | US7338781 Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof |
| 03/04/2008 | US7338772 RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate |
| 03/04/2008 | US7338770 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
| 03/04/2008 | US7338766 Activating adenine triphosphate independent cytolytic modulator for use in the treatment of infection and cancer; generate nutrient broth, propagate microorganisms, allow microorganism to secrete protein, recover protein; inhibiting parasitemia of Plasmodium falciparum |
| 03/04/2008 | US7338670 Administering agent that induces nitrosylation of hemoglobin andhyperoxic gas |
| 03/04/2008 | US7338658 Chimeric antibody specific to human CD4 which comprises the variable heavy and light chain sequences of an Old World monkey monoclonal antibody produced against human CD4 and human constant heavy and light domain sequences |
| 03/04/2008 | US7338656 Composition and method to alter lean body mass and bone properties in a subject |
| 03/04/2008 | US7338654 Glycosylated interferon alpha obtained from a transgenic chicken |
| 03/04/2008 | US7338653 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 03/04/2008 | US7338517 Tissue scaffold having aligned fibrils and artificial tissue comprising the same |
| 03/01/2008 | CA2598060A1 Methods and compositions for the treatment and prevention of cancer |
| 02/28/2008 | WO2008025031A1 Treatment of graft-versus-host disease |
| 02/28/2008 | WO2008024919A2 Interferon antagonists, antibodies thereto, and associated methods of use |
| 02/28/2008 | WO2008024858A2 Methods and compounds regulating the erythroid response to iron deficiency |
| 02/28/2008 | WO2008024843A2 Combination therapy method for treating hepatitis c virus infection and pharmaceutical compositions for use therein |
| 02/28/2008 | WO2008024509A2 Cationic latex as a carrier for bioactive ingredients and methods for making and using the same |
| 02/28/2008 | WO2008024498A2 A system for obfuscating identity |
| 02/28/2008 | WO2008024409A1 Progenitor cell replication and differentiation in 3d |
| 02/28/2008 | WO2008024300A1 SEMAPHORIN 7A PLAYS A CRITICAL ROLE IN TGF-β1-INDUCED PULMONARY FIBROSIS AND ALVEOLAR DESTRUCTION |
| 02/28/2008 | WO2008024299A2 Combination with bis(thiohydrazide amides) for treating cancer |
| 02/28/2008 | WO2008024285A2 Antibiotic compound |
| 02/28/2008 | WO2008024103A1 Compositions to reduce or prevent skin cancer |
| 02/28/2008 | WO2008024075A1 Modulators of candida hyphal morphogenesis and uses thereof |
| 02/28/2008 | WO2008023818A1 Fiber and method for production of fiber |
| 02/28/2008 | WO2008023796A1 Proteoglycan production accelerator |
| 02/28/2008 | WO2008023725A1 Preventive and/or therapeutic agent for peripheral neuropathy |
| 02/28/2008 | WO2008023717A1 Ophthalmic agent comprising pacap peptide |